Ardent Health Partners, LLC (NYSE:ARDT – Get Free Report) has received a consensus recommendation of “Buy” from the twelve research firms that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $21.82.
Several analysts recently commented on ARDT shares. Leerink Partnrs upgraded shares of Ardent Health Partners to a “strong-buy” rating in a report on Monday, August 12th. Royal Bank of Canada reissued an “outperform” rating and set a $23.00 target price on shares of Ardent Health Partners in a research note on Thursday, November 14th. Citigroup started coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They set a “buy” rating and a $21.00 price target on the stock. JPMorgan Chase & Co. assumed coverage on Ardent Health Partners in a report on Monday, August 12th. They set a “neutral” rating and a $18.00 price objective for the company. Finally, Leerink Partners boosted their target price on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a research note on Tuesday, November 12th.
Get Our Latest Stock Report on ARDT
Ardent Health Partners Price Performance
Institutional Investors Weigh In On Ardent Health Partners
A number of large investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets acquired a new stake in shares of Ardent Health Partners in the third quarter worth $42,000. Financial Management Professionals Inc. acquired a new position in Ardent Health Partners during the 3rd quarter worth $50,000. MetLife Investment Management LLC acquired a new position in Ardent Health Partners during the 3rd quarter worth $135,000. Quadrature Capital Ltd bought a new stake in Ardent Health Partners during the third quarter valued at about $229,000. Finally, Barclays PLC acquired a new stake in shares of Ardent Health Partners in the third quarter valued at about $385,000.
Ardent Health Partners Company Profile
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Recommended Stories
- Five stocks we like better than Ardent Health Partners
- What is Put Option Volume?
- Tesla Investors Continue to Profit From the Trump Trade
- ESG Stocks, What Investors Should Know
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- The Significance of Brokerage Rankings in Stock Selection
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.